Search | HMA-EMA Catalogues of real-world data sources and studies

Results(113)

DARWIN EU® - Time to onset of thromboembolic events in adults with selected types of cancer

Belgium

Denmark

Estonia

Finland

Germany

Netherlands

Spain

United Kingdom

EU PAS number:

EUPAS1000000814

First published:

10/11/2025

Last updated 13/05/2026

Study Finalised

DARWIN EU® Natural history of dermatomyositis (DM) and polymyositis (PM) in adults and paediatric populations

Estonia

France

Germany

Spain

United Kingdom

EU PAS number:

EUPAS107454

First published:

13/11/2023

Last updated 25/09/2024

Study Finalised

DARWIN EU® - Prevalence of hypertrophic cardiomyopathy (HCM) and obstructive hypertrophic cardiomyopathy (oHCM) in six European countries

Croatia

Denmark

Germany

Norway

Spain

United Kingdom

EU PAS number:

EUPAS1000000430

First published:

04/01/2025

Last updated 20/08/2026

Study Finalised

DARWIN EU® – Paracetamol prescribing and paracetamol overdose in Europe: a descriptive analysis of trends and patient characteristics

Denmark

France

Germany

Netherlands

Norway

Spain

Sweden

EU PAS number:

EUPAS1000000584

First published:

22/05/2025

Last updated 20/08/2026

Study Finalised

DARWIN EU® Treatment patterns of drugs used in adult and paediatric population with systemic lupus erythematosus

France

Germany

Spain

United Kingdom

EU PAS number:

EUPAS106436

First published:

06/09/2023

Last updated 14/08/2026

Study Finalised

DARWIN EU® – Paracetamol prescribing and paracetamol overdose in Europe: a descriptive analysis of trends and patient characteristics

Croatia

Denmark

France

Germany

Portugal

Spain

United Kingdom

EU PAS number:

EUPAS1000000329

First published:

04/10/2024

Last updated 11/08/2026

Study Finalised

DARWIN EU® - Representativeness of the clinical trial population compared with the real-world population with resistant hypertension

Belgium

Denmark

Finland

Netherlands

Spain

United States

EU PAS number:

EUPAS1000001065

First published:

17/07/2026

Last updated 11/08/2026

Study Ongoing

DARWIN EU® - Background incidence rates of selected vaccine adverse events of special interest (AESIs) in Europe

Germany

Netherlands

Norway

Spain

United Kingdom

EU PAS number:

EUPAS1000000254

First published:

10/07/2024

Last updated 10/08/2026

Study Finalised

DARWIN EU® Comparing direct and indirect methods to estimate prevalence of chronic diseases using real-world data

Netherlands

Spain

United Kingdom

EU PAS number:

EUPAS1000000088

First published:

27/03/2024

Last updated 25/09/2024

Study Finalised

DARWIN EU® - Suicidality incidence rates in adult male patients and in patients treated with finasteride and dutasteride

Croatia

Denmark

Germany

Netherlands

Spain

United Kingdom

EU PAS number:

EUPAS1000000423

First published:

19/12/2024

Last updated 20/08/2026

Study Finalised

DARWIN EU® - Real-World Overall Survival in Patients with Acute Gut GvHD Following Failure of Corticosteroids and Ruxolitinib

Belgium

Denmark

Germany

Spain

United States

EU PAS number:

EUPAS1000001062

First published:

16/07/2026

Last updated 20/08/2026

Study Ongoing

DARWIN EU® Drug utilisation study of medicines with prokinetic properties in children and adults diagnosed with gastroparesis

Belgium

France

Germany

Netherlands

Spain

United Kingdom

EU PAS number:

EUPAS106798

First published:

16/10/2023

Last updated 14/08/2026

Study Finalised

DARWIN EU® - Antipsychotic prescribing in the general population in Europe: a descriptive analysis of trends and patient characteristics

Belgium

Croatia

Denmark

Germany

Netherlands

Spain

EU PAS number:

EUPAS1000000330

First published:

04/10/2024

Last updated 11/08/2026

Study Finalised

DARWIN EU® - Antipsychotic prescribing in people with dementia in Europe: a descriptive analysis of trends and patient characteristics

Belgium

Croatia

Denmark

Germany

Netherlands

Spain

EU PAS number:

EUPAS1000000382

First published:

09/12/2024

Last updated 07/08/2026

Study Finalised

DARWIN EU® - Assess the role and performance of AI-based phenotyping in non-interventional studies

Germany

Netherlands

Spain

United Kingdom

EU PAS number:

EUPAS1000001107

First published:

07/09/2026

Last updated 07/09/2026

Study Ongoing

DARWIN EU® - Sex differences in prescribing of benzodiazepines and benzodiazepine-related drugs over time in adolescents and young adults.

Denmark

Finland

Germany

Netherlands

Spain

United Kingdom

EU PAS number:

EUPAS1000001096

First published:

25/08/2026

Last updated 25/08/2026

Study Planned

DARWIN EU® – Proof-of-concept: Preparedness for annual seasonal influenza vaccine effectiveness studies - Vaccine coverage and incidence of influenza-related outcomes

Croatia

Denmark

Finland

Norway

Spain

United Kingdom

EU PAS number:

EUPAS1000000803

First published:

05/11/2025

Last updated 20/08/2026

Study Finalised

DARWIN EU® Effectiveness of COVID-19 vaccines on severe COVID-19 and post acute outcomes of SARS-CoV-2 infection

Netherlands

Spain

United Kingdom

EU PAS number:

EUPAS107615

First published:

28/11/2023

Last updated 14/08/2026

Study Finalised

DARWIN EU® - Incidence of myoclonus in heart failure: a descriptive analysis in patients treated with sacubitril/valsartan and other treatments

Germany

Spain

United Kingdom

EU PAS number:

EUPAS1000000351

First published:

30/10/2024

Last updated 10/08/2026

Study Ongoing

DARWIN EU® - Assessing the feasibility of conducting a causal study on the potential association between beta-blockers and breast cancer

Denmark

Norway

Spain

Sweden

United Kingdom

EU PAS number:

EUPAS1000001013

First published:

02/06/2026

Last updated 07/07/2026

Study Ongoing

DARWIN EU® - Association of venous thromboembolism with non-steroidal anti-inflammatory drug use in women 15-49 years using hormonal contraceptives

Denmark

Norway

Spain

United Kingdom

EU PAS number:

EUPAS1000000443

First published:

16/01/2025

Last updated 21/07/2025

Study Finalised

DARWIN EU® - Background incidence rates of selected vaccine adverse events of special interest (AESIs) in Europe – supporting international preparedness

Denmark

Finland

Germany

Netherlands

Norway

Spain

Sweden

United Kingdom

EU PAS number:

EUPAS1000000969

First published:

04/05/2026

Last updated 27/08/2026

Study Finalised

DARWIN EU® - Impact of risk minimisation measures related to the risk of meningioma in women using nomegestrol and chlormadinone

Belgium

Croatia

Germany

EU PAS number:

EUPAS1000000455

First published:

28/01/2025

Last updated 14/08/2026

Study Finalised

DARWIN EU® – Benzodiazepine use during pregnancy: a descriptive study characterising exposure, pregnancy loss, and covariates to inform future safety studies

Norway

Spain

EU PAS number:

EUPAS1000000536

First published:

02/04/2025

Last updated 07/08/2026

Study Ongoing

DARWIN EU® - Characterisation of acute renal outcomes and diabetic complications among patients with concomitant use of metformin and iodinated contrast agents

Denmark

Finland

Spain

United Kingdom

EU PAS number:

EUPAS1000000662

First published:

03/07/2025

Last updated 31/03/2026

Study Finalised

DARWIN EU® DUS of Antibiotics in the ‘Watch’ category of the WHO AWaRe classification of antibiotics for evaluation and monitoring of use

France

Germany

Netherlands

Spain

United Kingdom

EU PAS number:

EUPAS103381

First published:

03/02/2023

Last updated 14/08/2026

Study Finalised

DARWIN EU® - Co-prescribing of endothelin receptor antagonists (ERAs) and phosphodiesterate-5 inhibitors (PDE-5is) in pulmonary arterial hypertension (PAH)

Estonia

France

Germany

United Kingdom

EU PAS number:

EUPAS106052

First published:

07/08/2023

Last updated 11/08/2026

Study Finalised

DARWIN EU® Overall survival in patients with locally advanced or metastatic non-small cell lung cancer treated with selected immunotherapies as first line of treatment

France

Netherlands

Spain

EU PAS number:

EUPAS1000000112

First published:

22/04/2024

Last updated 20/08/2026

Study Finalised

DARWIN EU® - Drug Utilisation Study on Antibiotics in the ‘Reserve’ category of the WHO AWaRe classification of antibiotics for evaluation and monitoring of use

Denmark

France

Greece

Hungary

Italy

Portugal

Spain

EU PAS number:

EUPAS1000000664

First published:

04/07/2025

Last updated 14/08/2026

Study Ongoing

DARWIN EU® - Drug utilisation study on antibiotics in the ‘Access’ category of the WHO AWaRe classification of antibiotics for evaluation and monitoring of use

Croatia

Denmark

Finland

Germany

Netherlands

Spain

EU PAS number:

EUPAS1000000663

First published:

04/07/2025

Last updated 14/08/2026

Study Finalised

DARWIN EU® - Drug Utilisation Study on Antibiotics in the ‘Watch’ category of the WHO AWaRe classification of antibiotics for evaluation and monitoring of use

Croatia

Denmark

Finland

France

Germany

Hungary

Netherlands

Spain

EU PAS number:

EUPAS1000000665

First published:

04/07/2025

Last updated 14/08/2026

Study Finalised

DARWIN EU® EHDS Use Case: Natural history of coagulopathy in COVID-19 patients and persons vaccinated against SARS-CoV-2 in the context of the OMICRON variant

Estonia

Germany

Netherlands

Spain

United Kingdom

EU PAS number:

EUPAS106679

First published:

03/10/2023

Last updated 10/03/2026

Study Finalised

DARWIN EU® - Background rates of serious adverse events to contextualise safety assessments in clinical trials and non-interventional studies in adolescent and adult patients with severe asthma

Estonia

Netherlands

Spain

United Kingdom

EU PAS number:

EUPAS103936

First published:

14/03/2023

Last updated 25/09/2024

Study Finalised

Search all content

Results(113)